# Mark R. Pittelkow

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-r-pittelkow/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,562 |
| Field | Cutaneous lymphoproliferative disorders research |
| h-index | 90 |
| i10-index | 290 |
| Last Known Institution | Mayo Clinic in Arizona |
| OpenAlex ID | https://openalex.org/A5073971261 |
| ORCID iD | https://orcid.org/0000-0001-7913-0294 |
| Works | 513 |

## Researcher papers

- [Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)](https://scholariq.org/papers/revisions-to-the-staging-and-classification-of-mycosis-fungoides-and-sezary/)
- [Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer](https://scholariq.org/papers/clinical-end-points-and-response-criteria-in-mycosis-fungoides-and-sezary/)
- [Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis](https://scholariq.org/papers/malignant-melanoma-in-the-21st-century-part-1-epidemiology-risk-factors/)
- [Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis](https://scholariq.org/papers/malignant-melanoma-in-the-21st-century-part-1-epidemiology-risk-factors-2/)
- [Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis](https://scholariq.org/papers/survival-risk-factors-and-effect-of-treatment-in-101-patients-with-calciphylaxis/)

## Researcher topics

- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [Mayo Clinic in Arizona](https://scholariq.org/institutions/mayo-clinic-in-arizona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.